Summary:
- SporeBio, a biotech startup, has raised $23 million in funding to develop machine learning-powered microbiology testing solutions.
- The company's technology aims to automate and streamline microbiology testing, which is currently a labor-intensive and time-consuming process.
- SporeBio's platform uses machine learning algorithms to analyze microbial samples and provide faster, more accurate results, potentially improving disease diagnosis and treatment.